AU5337690A - Method for stabilizing the hybridization of complementary polynucleotide sequences - Google Patents

Method for stabilizing the hybridization of complementary polynucleotide sequences

Info

Publication number
AU5337690A
AU5337690A AU53376/90A AU5337690A AU5337690A AU 5337690 A AU5337690 A AU 5337690A AU 53376/90 A AU53376/90 A AU 53376/90A AU 5337690 A AU5337690 A AU 5337690A AU 5337690 A AU5337690 A AU 5337690A
Authority
AU
Australia
Prior art keywords
hybridization
stabilizing
sequence
polynucleotide sequences
complementary polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53376/90A
Inventor
Benoit Prieur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OPALE BIOTECHNOLOGY
Original Assignee
OPALE BIOTECHNOLOGY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OPALE BIOTECHNOLOGY filed Critical OPALE BIOTECHNOLOGY
Publication of AU5337690A publication Critical patent/AU5337690A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6832—Enhancement of hybridisation reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3513—Protein; Peptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a method for stabilizing the hybridization of a first DNA or RNA polynucleotide sequence, modified or not, with an anomeric configuration $g(a) or $g(b) by means of a second target sequence complementary of the first DNA or RNA sequence, characterized in that a peptide optionally fixed to said first sequence is complexed on the double hybridization helix formed by said first and second nucleotide sequences. The present invention also relates to peptide-polynucleotide conjugates useful for the method, as well as their application as diagnostic probes or as therapeutic agents, in particular.
AU53376/90A 1989-03-14 1990-03-13 Method for stabilizing the hybridization of complementary polynucleotide sequences Abandoned AU5337690A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8903303A FR2644461B1 (en) 1989-03-14 1989-03-14 PROCESS FOR STABILIZING THE HYBRIDIZATION OF COMPLEMENTARY POLYNUCLEOTIDE SEQUENCES, PEPTIDE-POLYNUCLEOTIDE CONJUGATES USEFUL FOR THE IMPLEMENTATION OF THE PROCESS
FR8903303 1989-03-14

Publications (1)

Publication Number Publication Date
AU5337690A true AU5337690A (en) 1990-10-09

Family

ID=9379652

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53376/90A Abandoned AU5337690A (en) 1989-03-14 1990-03-13 Method for stabilizing the hybridization of complementary polynucleotide sequences

Country Status (10)

Country Link
EP (1) EP0463043B1 (en)
JP (1) JPH04506450A (en)
AT (1) ATE105871T1 (en)
AU (1) AU5337690A (en)
CA (1) CA2050913A1 (en)
DE (1) DE69009050T2 (en)
DK (1) DK0463043T3 (en)
ES (1) ES2056458T3 (en)
FR (1) FR2644461B1 (en)
WO (1) WO1990010713A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993020090A1 (en) * 1992-04-06 1993-10-14 University Of Medicine & Dentistry Of New Jersey Paired-ion oligonucleotides and methods for preparing same
US5556752A (en) * 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA

Also Published As

Publication number Publication date
EP0463043B1 (en) 1994-05-18
JPH04506450A (en) 1992-11-12
ES2056458T3 (en) 1994-10-01
EP0463043A1 (en) 1992-01-02
FR2644461A1 (en) 1990-09-21
DK0463043T3 (en) 1994-10-10
WO1990010713A1 (en) 1990-09-20
ATE105871T1 (en) 1994-06-15
DE69009050D1 (en) 1994-06-23
CA2050913A1 (en) 1990-09-15
FR2644461B1 (en) 1993-12-17
DE69009050T2 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
AU6589094A (en) 7-deazapurine modified oligonucleotides
CA2020958A1 (en) Nucleic acid sequence amplification methods
BG101103A (en) Mammalian telomerase
EP0731175A3 (en) Oligonucleotide probes for HIV nucleic acid
FR2637612B1 (en) NUCLEOTIDE SEQUENCES ENCODING A PROTEIN WITH UREASIC ACTIVITY
ATE267207T1 (en) CARBOHYDRATE MODIFIED LATCH OLIGONUCLEOTIDES
CA2194761A1 (en) Immunomodulatory oligonucleotides
AU3728897A (en) Methods for detecting and amplifying nucleic acid sequences using modified oligonucleotides having increased target specific Tm
CA2172722A1 (en) Methods and compositions for efficient nucleic acid sequencing
DE69233599D1 (en) Broken 2'-modified oligonucleotides
ES2108748T3 (en) AMPLIFICATION OF NUCLEIC ACIDS WITH DNA DEPENDENT RNA POLYMERASE ACTIVITY, OF RNA REPLICASES.
ATE238434T1 (en) A CASCADED DUPLICATION REACTION OF NUCLEIC ACIDS
WO1996001614A3 (en) Rna component of telomerase
DE3785343D1 (en) ALPHA OLIGONUCLEOTIDES.
AU9355698A (en) Novel nucleoside or nucleotide fluorescent conjugates, preparation method and uses
AU5337690A (en) Method for stabilizing the hybridization of complementary polynucleotide sequences
WO1990000607A3 (en) Gap gene sequences and diagnostic uses thereof
CA2099503A1 (en) Synthetic alpha-l-iduronidase and genetic sequences encoding same
AU2806597A (en) Human DNase II
EP0844305A3 (en) hRAD54
WO1994015967B1 (en) Agents for the prevention and treatment of parkinson's disease
IT1256078B (en) SOLUBLE KIT LIGANDS
ES2021482A6 (en) Procedure for preparation of synthetic oligonucleotides and for gene amplification of specific DNA molecular probes for the male genome of ruminants